Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
LBT Innovations Ltd
LBTLBT Innovations Limited engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, and Germany. The company offers Automated Plate Assessment System (APAS) Independence, a solution that automates the imaging, analysis, and interpretation of microbiology culture plates primarily for microbiology laboratories and pharmaceutical manufacturing sector; APAS Analysis Modules, a software algorithm that enables the screening of microbiology culture plates collected during environmental monitoring; and APAS PharmaQC, an artificial intelligence for culture plate reading. It also develops APAS intelligent imaging technology for various applications, which includes wound treatment, histopathology, and antimicrobial susceptibility testing. LBT Innovations Limited was incorporated in 2004 and is headquartered in Adelaide, Australia. Address: 16 Anster Street, Adelaide, SA, Australia, 5000
Analytics
WallStreetin tavoitehinta
0.3 AUDP/E-suhde
–Osinkotuotto
–Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut LBT
Osinkoanalytiikka LBT
Osinkojen kasvu 5 vuoden aikana
–Jatkuva kasvu
–Maksusuhde 5 vuoden keskiarvo
–Osinkohistoria LBT
Osakkeen arvostus LBT
Talousasiat LBT
Tuloksia | 2019 | Dynamiikka |